Carsten Boess
CIK: 0001277495
Associated companies
Transaction History
| RCKT | ▲ Buy | Grant | 22,862 | $0 | 6/18/2026 | View on chart |
| RCKT | ▲ Buy | Grant | 30,000 | $0 | 6/18/2025 | View on chart |
| RCKT | ▲ Buy | Grant | 22,862 | $0 | 6/18/2026 | View on chart |
| RCKT | ▲ Buy | Grant | 30,000 | $0 | 6/18/2025 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
Rocket Pharmaceuticals Gets FDA Alignment on Heart Drug Trial
Rocket Pharmaceuticals has secured FDA alignment on a trial for its heart drug, which may help address prior safety concerns. This regulatory step is significant for the company's development timeline. The stock is currently trading near its 52-week low, reflecting ongoing market caution despite this progress.
Rocket Pharmaceuticals Gets FDA Alignment on Heart Drug Trial. Rocket Pharmaceuticals has secured FDA alignment on a trial for its heart drug, which may help address prior safety concerns. This regulatory step is significant for the company's development timeline. The stock is currently trading near its 52-week low, reflecting ongoing market caution despite this progress.